{"id":"https://openalex.org/W4288740595","doi":"https://doi.org/10.33920/med-03-2207-02","title":"Antiexudative activity of new 1,4\u2011dihydropyridine derivatives","display_name":"Antiexudative activity of new 1,4\u2011dihydropyridine derivatives","publication_year":2022,"publication_date":"2022-07-01","ids":{"openalex":"https://openalex.org/W4288740595","doi":"https://doi.org/10.33920/med-03-2207-02"},"language":"en","primary_location":{"id":"doi:10.33920/med-03-2207-02","doi":"https://doi.org/10.33920/med-03-2207-02","is_oa":false,"landing_page_url":"https://doi.org/10.33920/med-03-2207-02","pdf_url":null,"source":{"id":"https://openalex.org/S4306511536","display_name":"Glavvra\u010d (Chief Medical Officer)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Glavvra\u010d (Chief Medical Officer)","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072469098","display_name":"E. Yu. Bibik","orcid":"https://orcid.org/0000-0002-2622-186X","observed_orcids":["https://orcid.org/0000-0002-2622-186X","https://orcid.org/0000-0001-7470-608X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E.Yu. Bibik","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2622-186X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047018088","display_name":"A. A. Samokish","orcid":"https://orcid.org/0000-0001-9285-3681","observed_orcids":["https://orcid.org/0000-0001-9285-3681"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A.A. Samokish","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032005615","display_name":"Yu. S. Venidiktova","orcid":"https://orcid.org/0000-0002-6649-511X","observed_orcids":["https://orcid.org/0000-0002-6649-511X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu.S. Venidiktova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064456753","display_name":"Bogdan S. Krivokolysko","orcid":"https://orcid.org/0000-0002-3181-7609","observed_orcids":["https://orcid.org/0000-0002-3181-7609"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B.S. Krivokolysko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008658007","display_name":"\u0411\u0438\u0431\u0438\u043a \u0418\u0433\u043e\u0440\u044c \u0412\u0430\u043b\u0435\u0440\u044c\u0435\u0432\u0438\u0447","orcid":"https://orcid.org/0000-0003-4053-1431","observed_orcids":["https://orcid.org/0000-0003-4053-1431"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I.V. Bibik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082410136","display_name":"Victor V. Dotsenko","orcid":"https://orcid.org/0000-0001-7163-0497","observed_orcids":["https://orcid.org/0000-0001-7163-0497"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V.V. Dotsenko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5077792786","display_name":"S.G. Krivokolysko","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S.G. Krivokolysko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":"7","first_page":"12","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.7455999851226807,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.7455999851226807,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.16580000519752502,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/1-4-dihydropyridines","display_name":"1,4-dihydropyridines","score":0.9409999847412109},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.902999997138977},{"id":"https://openalex.org/keywords/formalin-induced-paw-edema","display_name":"formalin-induced paw edema","score":0.890999972820282},{"id":"https://openalex.org/keywords/edema-inhibition","display_name":"edema inhibition","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C2781212610","wikidata":"https://www.wikidata.org/wiki/Q39094","display_name":"Dihydropyridine","level":3,"score":0.6544348001480103},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5246270298957825},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4835948348045349},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24832531809806824},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.13248950242996216},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.10175198316574097}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.33920/med-03-2207-02","doi":"https://doi.org/10.33920/med-03-2207-02","is_oa":false,"landing_page_url":"https://doi.org/10.33920/med-03-2207-02","pdf_url":null,"source":{"id":"https://openalex.org/S4306511536","display_name":"Glavvra\u010d (Chief Medical Officer)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Glavvra\u010d (Chief Medical Officer)","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4212997999","https://openalex.org/W4392545014","https://openalex.org/W2759067914","https://openalex.org/W2264509297","https://openalex.org/W2276235495","https://openalex.org/W2095334838","https://openalex.org/W2414636106","https://openalex.org/W2410420688","https://openalex.org/W2293439596","https://openalex.org/W2767551115"],"abstract_inverted_index":{"The":[0],"purpose":[1],"of":[2,10,20],"the":[3,7,17],"study:":[4],"to":[5],"determine":[6],"antiexudative":[8],"activity":[9],"new":[11],"compounds":[12],"-":[13],"1,4-dihydrothiopyridine":[14],"derivatives":[15],"in":[16],"classical":[18],"test":[19],"formalin":[21],"paw":[22],"edema":[23],"on":[24],"white":[25],"rats.":[26]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2022-07-30T00:00:00"}